FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 215814 | NDA | RIGEL PHARMS | | 001 | REZLIDHIA | CAPSULE;ORAL | 150MG | OLUTASIDENIB | 2022-12-01 | Prescription | Yes |
| 213721 | NDA | RIGEL PHARMS | | 001 | GAVRETO | CAPSULE;ORAL | 100MG | PRALSETINIB | 2020-09-04 | Prescription | Yes |
| 209299 | NDA | RIGEL PHARMS | | 001 | TAVALISSE | TABLET;ORAL | EQ 100MG BASE | FOSTAMATINIB DISODIUM | 2018-04-17 | Prescription | No |
| 002 | TAVALISSE | TABLET;ORAL | EQ 150MG BASE | FOSTAMATINIB DISODIUM | 2018-04-17 | Prescription | Yes |